Related Experiment Video
Updated: Apr 21, 2026
10:28
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
11.7K
[Obesity and gastrointestinal neoplasms]
Izabela Binkowska-Borgosz1, Teresa Starzyńska1, Wojciech Błogowski2
1Katedra i Klinika Gastroenterologii Pomorskiego Uniwersytetu Medycznego w Szczecinie.
Postepy Higieny I Medycyny Doswiadczalnej (Online)
|November 8, 2014
Summary
Obesity is a major health issue linked to numerous diseases. Emerging evidence strongly associates excess adipose tissue with an increased risk of developing various cancers, particularly gastrointestinal neoplasms.
Area of Science:
- Metabolic research
- Oncology
- Public health
Background:
- Obesity is a widespread 21st-century public health concern.
- Adipose tissue accumulation is a risk factor for cardiovascular and skeletal diseases.
- Obesity is increasingly recognized as a significant risk factor for numerous cancers, including gastrointestinal cancers.
Purpose of the Study:
- To review the mechanisms linking adipose tissue metabolism to cancer development.
- To explore the association between obesity and gastrointestinal cancer risk.
- To present current knowledge and clinical study findings on this relationship.
Main Methods:
- Review of current scientific literature.
- Analysis of epidemiological data.
- Synthesis of findings on metabolic pathways and clinical outcomes.
Main Results:
- Adipose tissue metabolism plays a key role in neoplasm development and progression.
- Epidemiological studies confirm a strong link between obesity and gastrointestinal cancer risk.
- Clinical studies provide further evidence for obesity's influence on gastrointestinal cancer incidence.
Conclusions:
- Obesity is a critical factor in the development of gastrointestinal cancers.
- Understanding the (patho)mechanisms is crucial for prevention and treatment strategies.
- Further research into the obesity-cancer link is warranted.
Related Concept Videos
01:11Pyloric Obstruction
19
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...
19
01:24Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
01:20Gastrointestinal Motility Disorders
1.7K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.7K
01:07Intestinal Obstruction II: Pathophysiology
25
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
25
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
431
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
431
01:21Barrett Esophagus-II: Clinical Manifestations and Management
1.7K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.7K